Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response

B S Alpert et al. J Pediatr. 1979 Oct.

. 1979 Oct;95(4):578-82.

doi: 10.1016/s0022-3476(79)80774-x.

No abstract available

Cited by

Indomethacin in closure of patent ductus arteriosus.
Vedanarayanan VV, Verma IC. Vedanarayanan VV, et al. Indian J Pediatr. 1981 Jul-Aug;48(393):477-80. doi: 10.1007/BF02822293. Indian J Pediatr. 1981. PMID: 7327640 No abstract available.
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).
Besunder JB, Reed MD, Blumer JL. Besunder JB, et al. Clin Pharmacokinet. 1988 May;14(5):261-86. doi: 10.2165/00003088-198814050-00001. Clin Pharmacokinet. 1988. PMID: 3293867 Review. No abstract available.
Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.
Mrongovius R, Imbeck H, Wille L, Müller H, Seyberth HW. Mrongovius R, et al. Eur J Pediatr. 1982 Mar;138(2):151-3. doi: 10.1007/BF00441143. Eur J Pediatr. 1982. PMID: 7094936
Prostaglandin levels: predictors of indomethacin responsiveness.
Hammerman C, Zaia W, Berger S, Strates E, Aldousany A. Hammerman C, et al. Pediatr Cardiol. 1986;7(2):61-5. doi: 10.1007/BF02328952. Pediatr Cardiol. 1986. PMID: 3467304
Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
Brion LP, Campbell DE. Brion LP, et al. Cochrane Database Syst Rev. 2000;2001(2):CD001148. doi: 10.1002/14651858.CD001148. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(3):CD001148. doi: 10.1002/14651858.CD001148. PMID: 10796253 Free PMC article. Updated.